Showing results (41-50 of 121) with videos related to
Sort By:
Pageof 13
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1978
Sodium valproate in the treatment of levodopa-induced dyskinesiaP A Price, J D Parkes, C D MarsdenThe British Journal of Dermatology|July 1, 1984
Erythromelalgia following pergolide administrationB E Monk, J D Parkes, A Du VivierJournal of Neurology, Neurosurgery, and Psychiatry|November 1, 1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopaJ D Parkes, A G Debono, C D MarsdenEnvironmental Monitoring and Assessment|October 24, 2006
Inorganic nitrogen transformations in the treatment of landfill leachate with a high ammonium load: A case studyStephen D Parkes, Dianne F Jolley, Stephen R WilsonMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.Transplantation|December 2, 2016
Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant RejectionMichael D Parkes, Philip F Halloran, Luis G HidalgoExperimental Cell Research|March 15, 1997
ES cell cycle rates affect gene targeting frequenciesG B Udy, B D Parkes, D N WellsPsychological Medicine|February 1, 1976
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disabilityR H Mindham, C D Marsden, J D ParkesBritish Journal of Clinical Pharmacology|June 1, 1977
Amphetamines, growth hormone and narcolepsyJ D Parkes, A G Debono, P Jenner, et al.Molecular Endocrinology (Baltimore, Md.)|October 1, 1993
Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamusD Parkes, S Rivest, S Lee, et al.Pageof 13